| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 35 | 2024 | 3816 | 1.810 |
Why?
|
| Delirium | 17 | 2024 | 1663 | 1.710 |
Why?
|
| Proto-Oncogene Proteins c-ets | 25 | 2016 | 311 | 1.550 |
Why?
|
| Proteome | 17 | 2024 | 1855 | 1.420 |
Why?
|
| Proto-Oncogene Proteins | 25 | 2023 | 4485 | 1.280 |
Why?
|
| Blood Proteins | 8 | 2024 | 1173 | 1.200 |
Why?
|
| NF-kappa B | 21 | 2015 | 2472 | 1.080 |
Why?
|
| Nasal Polyps | 9 | 2020 | 395 | 0.990 |
Why?
|
| Transcription Factors | 37 | 2014 | 12094 | 0.940 |
Why?
|
| Relaxation Therapy | 2 | 2018 | 179 | 0.840 |
Why?
|
| Rhinitis | 9 | 2020 | 746 | 0.840 |
Why?
|
| DNA-Binding Proteins | 31 | 2011 | 9574 | 0.750 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 13 | 2023 | 2872 | 0.720 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2016 | 8506 | 0.700 |
Why?
|
| Nuclear Proteins | 22 | 2016 | 5786 | 0.690 |
Why?
|
| Sinusitis | 8 | 2020 | 990 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-jun | 4 | 2011 | 285 | 0.640 |
Why?
|
| Exosomes | 6 | 2022 | 423 | 0.640 |
Why?
|
| Postoperative Complications | 15 | 2024 | 15637 | 0.630 |
Why?
|
| Apoptosis | 24 | 2024 | 9468 | 0.620 |
Why?
|
| C-Reactive Protein | 7 | 2021 | 3812 | 0.600 |
Why?
|
| Gene Expression Profiling | 35 | 2022 | 9404 | 0.590 |
Why?
|
| Relaxation | 2 | 2018 | 51 | 0.580 |
Why?
|
| Cell Cycle Proteins | 8 | 2016 | 3442 | 0.560 |
Why?
|
| Carcinoma, Renal Cell | 8 | 2014 | 3217 | 0.560 |
Why?
|
| Pre-Eclampsia | 4 | 2022 | 1227 | 0.550 |
Why?
|
| Gene Expression Regulation | 28 | 2018 | 11892 | 0.510 |
Why?
|
| Interleukin-6 | 10 | 2022 | 3208 | 0.490 |
Why?
|
| Heart Arrest, Induced | 4 | 2012 | 357 | 0.490 |
Why?
|
| Transcriptional Activation | 15 | 2007 | 1752 | 0.470 |
Why?
|
| Pentamidine | 1 | 2014 | 44 | 0.470 |
Why?
|
| Adenoviridae | 6 | 2005 | 1084 | 0.460 |
Why?
|
| Promoter Regions, Genetic | 30 | 2011 | 5779 | 0.440 |
Why?
|
| Transcription, Genetic | 26 | 2012 | 7590 | 0.430 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 24 | 2015 | 3774 | 0.420 |
Why?
|
| Prostatic Neoplasms | 13 | 2023 | 11336 | 0.420 |
Why?
|
| Case-Control Studies | 18 | 2024 | 22029 | 0.410 |
Why?
|
| Up-Regulation | 19 | 2022 | 4113 | 0.410 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2009 | 507 | 0.390 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 20 | 2011 | 4567 | 0.370 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 2023 | 72 | 0.370 |
Why?
|
| Base Sequence | 26 | 2012 | 12436 | 0.370 |
Why?
|
| Molecular Sequence Data | 30 | 2012 | 17617 | 0.370 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1020 | 0.370 |
Why?
|
| Trans-Activators | 10 | 2012 | 2860 | 0.370 |
Why?
|
| Exocrine Glands | 1 | 2010 | 46 | 0.360 |
Why?
|
| Endometriosis | 3 | 2024 | 874 | 0.360 |
Why?
|
| Pyloric Antrum | 1 | 2010 | 66 | 0.360 |
Why?
|
| Humans | 196 | 2024 | 758406 | 0.360 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 10 | 2024 | 3801 | 0.350 |
Why?
|
| Mucus | 2 | 2018 | 342 | 0.340 |
Why?
|
| Meditation | 1 | 2013 | 251 | 0.340 |
Why?
|
| Kidney Neoplasms | 6 | 2011 | 4312 | 0.340 |
Why?
|
| Mitochondrial Proteins | 3 | 2009 | 977 | 0.340 |
Why?
|
| MAP Kinase Kinase 4 | 3 | 2011 | 149 | 0.330 |
Why?
|
| B-Lymphocytes | 8 | 2014 | 4738 | 0.330 |
Why?
|
| Yoga | 1 | 2013 | 281 | 0.330 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2024 | 2292 | 0.310 |
Why?
|
| Membrane Proteins | 11 | 2016 | 7843 | 0.310 |
Why?
|
| Inflammation | 19 | 2024 | 10718 | 0.300 |
Why?
|
| Cell Line | 31 | 2012 | 15591 | 0.300 |
Why?
|
| Lipopolysaccharides | 6 | 2022 | 2204 | 0.300 |
Why?
|
| Aptamers, Nucleotide | 2 | 2019 | 163 | 0.300 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2012 | 2753 | 0.290 |
Why?
|
| Cell Line, Tumor | 25 | 2020 | 16886 | 0.290 |
Why?
|
| Islets of Langerhans Transplantation | 4 | 2012 | 738 | 0.290 |
Why?
|
| Interleukin-1 | 6 | 2003 | 1249 | 0.290 |
Why?
|
| Chemokines, CXC | 2 | 2007 | 421 | 0.290 |
Why?
|
| Aged | 46 | 2024 | 168218 | 0.280 |
Why?
|
| Signal Transduction | 29 | 2019 | 23342 | 0.280 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 1996 | 649 | 0.280 |
Why?
|
| Cullin Proteins | 2 | 2023 | 178 | 0.270 |
Why?
|
| Albuminuria | 1 | 2010 | 650 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2012 | 2269 | 0.270 |
Why?
|
| Interleukins | 2 | 2011 | 783 | 0.270 |
Why?
|
| RNA, Messenger | 23 | 2019 | 12759 | 0.260 |
Why?
|
| Male | 83 | 2024 | 358747 | 0.260 |
Why?
|
| Protein Array Analysis | 3 | 2012 | 401 | 0.250 |
Why?
|
| Down-Regulation | 8 | 2022 | 2904 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 557 | 0.250 |
Why?
|
| Liver Neoplasms | 4 | 2024 | 4313 | 0.250 |
Why?
|
| Energy Metabolism | 3 | 2013 | 2868 | 0.250 |
Why?
|
| Female | 79 | 2024 | 390323 | 0.250 |
Why?
|
| Cell Differentiation | 15 | 2021 | 11471 | 0.250 |
Why?
|
| Animals | 85 | 2023 | 167768 | 0.250 |
Why?
|
| Chondrocytes | 5 | 2010 | 791 | 0.250 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 1724 | 0.240 |
Why?
|
| Myelodysplastic Syndromes | 4 | 2009 | 1392 | 0.240 |
Why?
|
| Genes | 6 | 2010 | 1845 | 0.240 |
Why?
|
| Oligonucleotides | 3 | 2023 | 582 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2007 | 585 | 0.240 |
Why?
|
| Enzyme Induction | 1 | 2005 | 451 | 0.240 |
Why?
|
| Pelvic Pain | 2 | 2024 | 298 | 0.240 |
Why?
|
| Mice | 57 | 2023 | 81101 | 0.240 |
Why?
|
| Antineoplastic Agents | 16 | 2015 | 13591 | 0.240 |
Why?
|
| Sulindac | 3 | 2011 | 29 | 0.230 |
Why?
|
| Blotting, Western | 9 | 2015 | 5031 | 0.230 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 1018 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 318 | 0.230 |
Why?
|
| Religion | 2 | 2021 | 376 | 0.230 |
Why?
|
| Genetic Vectors | 6 | 2004 | 3380 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2011 | 3574 | 0.220 |
Why?
|
| Amino Acid Sequence | 18 | 2012 | 13447 | 0.220 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 3609 | 0.220 |
Why?
|
| src-Family Kinases | 2 | 2004 | 535 | 0.220 |
Why?
|
| Eosinophils | 2 | 2018 | 946 | 0.220 |
Why?
|
| Adenocarcinoma | 3 | 2016 | 6313 | 0.210 |
Why?
|
| Genes, p53 | 1 | 2005 | 712 | 0.210 |
Why?
|
| Inflammation Mediators | 4 | 2024 | 1878 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 3 | 1996 | 1356 | 0.210 |
Why?
|
| Blood Pressure | 2 | 2018 | 8451 | 0.210 |
Why?
|
| Osteoblasts | 3 | 2018 | 1142 | 0.210 |
Why?
|
| Ovarian Neoplasms | 5 | 2012 | 4876 | 0.210 |
Why?
|
| Transfection | 13 | 2008 | 5779 | 0.210 |
Why?
|
| Receptors, Cell Surface | 16 | 2006 | 2825 | 0.200 |
Why?
|
| Raynaud Disease | 1 | 2022 | 79 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2012 | 4342 | 0.200 |
Why?
|
| Cloning, Molecular | 10 | 2002 | 4169 | 0.200 |
Why?
|
| Binding Sites | 15 | 2014 | 6036 | 0.200 |
Why?
|
| Cell Division | 5 | 2006 | 4458 | 0.200 |
Why?
|
| alpha 1-Antitrypsin | 3 | 2012 | 169 | 0.200 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 2010 | 788 | 0.190 |
Why?
|
| Computational Biology | 5 | 2023 | 3502 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2011 | 74 | 0.190 |
Why?
|
| Neutrophil Activation | 2 | 2019 | 181 | 0.190 |
Why?
|
| Nephrotic Syndrome | 2 | 2021 | 391 | 0.190 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2015 | 1613 | 0.190 |
Why?
|
| Pulmonary Atelectasis | 1 | 2022 | 143 | 0.190 |
Why?
|
| Carrier Proteins | 4 | 2014 | 4938 | 0.190 |
Why?
|
| Gene Targeting | 2 | 2006 | 837 | 0.190 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2024 | 192 | 0.190 |
Why?
|
| Gene Expression | 13 | 2014 | 7583 | 0.190 |
Why?
|
| Interleukin-2 | 1 | 2007 | 1888 | 0.180 |
Why?
|
| Gene Regulatory Networks | 5 | 2018 | 1740 | 0.180 |
Why?
|
| Liver | 8 | 2012 | 7502 | 0.180 |
Why?
|
| Insulin | 4 | 2013 | 6578 | 0.180 |
Why?
|
| Receptor, TIE-2 | 4 | 2018 | 176 | 0.180 |
Why?
|
| Microarray Analysis | 3 | 2014 | 746 | 0.180 |
Why?
|
| Ischemia | 1 | 2009 | 1863 | 0.180 |
Why?
|
| Cytokines | 6 | 2021 | 7338 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 607 | 0.180 |
Why?
|
| Endothelium, Vascular | 7 | 2019 | 4429 | 0.180 |
Why?
|
| Synovial Membrane | 1 | 2003 | 524 | 0.170 |
Why?
|
| Monocytes | 4 | 2019 | 2570 | 0.170 |
Why?
|
| Keratinocytes | 3 | 2000 | 790 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2023 | 400 | 0.170 |
Why?
|
| Oligonucleotide Probes | 5 | 2003 | 416 | 0.170 |
Why?
|
| Fanconi Anemia | 1 | 2022 | 324 | 0.170 |
Why?
|
| Capillary Leak Syndrome | 1 | 2019 | 32 | 0.170 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2011 | 441 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2019 | 3384 | 0.170 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2020 | 187 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2020 | 747 | 0.170 |
Why?
|
| Fatty Acids | 3 | 2020 | 1803 | 0.170 |
Why?
|
| Astrocytes | 3 | 2020 | 1337 | 0.160 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2018 | 841 | 0.160 |
Why?
|
| Hypertension | 2 | 2018 | 8499 | 0.160 |
Why?
|
| Salivary Cystatins | 1 | 2018 | 11 | 0.160 |
Why?
|
| Complement C7 | 1 | 2018 | 17 | 0.160 |
Why?
|
| Atrophy | 1 | 2024 | 1627 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 6 | 2019 | 1958 | 0.160 |
Why?
|
| Osteitis | 1 | 2018 | 33 | 0.160 |
Why?
|
| Genome, Human | 3 | 2010 | 4416 | 0.160 |
Why?
|
| Receptors, Complement 3d | 2 | 2014 | 117 | 0.160 |
Why?
|
| Scleroderma, Systemic | 1 | 2022 | 344 | 0.160 |
Why?
|
| Nasal Mucosa | 2 | 2019 | 412 | 0.160 |
Why?
|
| Peroxiredoxins | 1 | 2018 | 51 | 0.160 |
Why?
|
| DNA, Complementary | 5 | 2009 | 1991 | 0.160 |
Why?
|
| Diet, Gluten-Free | 1 | 2021 | 280 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 12 | 2016 | 6127 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 3 | 2008 | 832 | 0.160 |
Why?
|
| Adult | 43 | 2024 | 219935 | 0.160 |
Why?
|
| Proteinuria | 3 | 2007 | 594 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 367 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5349 | 0.150 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 333 | 0.150 |
Why?
|
| Ileum | 1 | 2020 | 555 | 0.150 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 707 | 0.150 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 4540 | 0.150 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2018 | 138 | 0.150 |
Why?
|
| Esophagus | 1 | 2024 | 1023 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 345 | 0.150 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 306 | 0.150 |
Why?
|
| Transplantation | 1 | 2019 | 218 | 0.150 |
Why?
|
| Immunoprecipitation | 4 | 2009 | 877 | 0.150 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2018 | 284 | 0.150 |
Why?
|
| Prospective Studies | 15 | 2024 | 54137 | 0.150 |
Why?
|
| Dairy Products | 1 | 2021 | 491 | 0.150 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2020 | 314 | 0.150 |
Why?
|
| Mice, Nude | 5 | 2020 | 3602 | 0.150 |
Why?
|
| Neutrophils | 3 | 2019 | 3765 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 350 | 0.150 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2019 | 175 | 0.150 |
Why?
|
| Middle Aged | 39 | 2024 | 219568 | 0.150 |
Why?
|
| Metabolomics | 2 | 2024 | 1629 | 0.150 |
Why?
|
| Mice, SCID | 6 | 2015 | 2626 | 0.150 |
Why?
|
| Neoplasms, Glandular and Epithelial | 3 | 2007 | 487 | 0.140 |
Why?
|
| Liver Regeneration | 2 | 2011 | 213 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2022 | 707 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2022 | 3480 | 0.140 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 187 | 0.140 |
Why?
|
| Viral Matrix Proteins | 2 | 2013 | 196 | 0.140 |
Why?
|
| Cluster Analysis | 7 | 2020 | 2697 | 0.140 |
Why?
|
| Antigens, CD34 | 5 | 2019 | 653 | 0.140 |
Why?
|
| Valproic Acid | 2 | 2010 | 442 | 0.140 |
Why?
|
| Orthopedic Procedures | 3 | 2022 | 1263 | 0.140 |
Why?
|
| RNA, Small Interfering | 5 | 2011 | 3432 | 0.140 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 326 | 0.140 |
Why?
|
| Diabetic Nephropathies | 2 | 2018 | 973 | 0.140 |
Why?
|
| Organ Specificity | 5 | 2010 | 1955 | 0.140 |
Why?
|
| Graft Rejection | 3 | 2019 | 4426 | 0.140 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2018 | 251 | 0.140 |
Why?
|
| Cyclin D3 | 1 | 2016 | 54 | 0.130 |
Why?
|
| 5'-Nucleotidase | 2 | 2008 | 161 | 0.130 |
Why?
|
| Placenta Accreta | 1 | 2020 | 237 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2009 | 1134 | 0.130 |
Why?
|
| Cells, Cultured | 22 | 2010 | 18940 | 0.130 |
Why?
|
| Phosphorylation | 13 | 2019 | 8297 | 0.130 |
Why?
|
| Antigens, Differentiation | 2 | 2010 | 911 | 0.130 |
Why?
|
| Protein Binding | 8 | 2013 | 9311 | 0.130 |
Why?
|
| Facial Transplantation | 1 | 2018 | 221 | 0.130 |
Why?
|
| Myocardium | 6 | 2012 | 4690 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2005 | 1171 | 0.130 |
Why?
|
| Cell Cycle | 4 | 2015 | 2930 | 0.130 |
Why?
|
| RNA Interference | 4 | 2011 | 2836 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2012 | 2825 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1997 | 635 | 0.120 |
Why?
|
| Antigens, Nuclear | 2 | 2007 | 184 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2011 | 3593 | 0.120 |
Why?
|
| Bacterial Typing Techniques | 1 | 2016 | 260 | 0.120 |
Why?
|
| Blood Coagulation Disorders | 1 | 2018 | 349 | 0.120 |
Why?
|
| Reproducibility of Results | 11 | 2022 | 20055 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 15399 | 0.120 |
Why?
|
| Chemokines | 1 | 1999 | 961 | 0.120 |
Why?
|
| Multigene Family | 5 | 2007 | 1076 | 0.120 |
Why?
|
| Prostaglandins E | 1 | 1994 | 169 | 0.120 |
Why?
|
| Phenylurea Compounds | 2 | 2015 | 529 | 0.120 |
Why?
|
| Capsid | 3 | 2002 | 434 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2024 | 4159 | 0.120 |
Why?
|
| Metformin | 1 | 2022 | 907 | 0.120 |
Why?
|
| Genomics | 4 | 2023 | 5790 | 0.120 |
Why?
|
| Nose | 1 | 2018 | 519 | 0.120 |
Why?
|
| Serum Response Factor | 1 | 2014 | 78 | 0.120 |
Why?
|
| Endothelial Cells | 5 | 2019 | 3533 | 0.120 |
Why?
|
| Mutation | 14 | 2020 | 29915 | 0.120 |
Why?
|
| Cytoplasm | 3 | 2009 | 1514 | 0.120 |
Why?
|
| Virus Attachment | 1 | 2014 | 55 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1436 | 0.110 |
Why?
|
| Focal Adhesions | 1 | 2014 | 114 | 0.110 |
Why?
|
| Cell Survival | 7 | 2012 | 5781 | 0.110 |
Why?
|
| Liver Cirrhosis | 3 | 2010 | 1930 | 0.110 |
Why?
|
| Chronic Disease | 8 | 2020 | 9267 | 0.110 |
Why?
|
| DNA Primers | 5 | 2005 | 2816 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 982 | 0.110 |
Why?
|
| Antiprotozoal Agents | 1 | 2014 | 94 | 0.110 |
Why?
|
| Aged, 80 and over | 15 | 2024 | 58683 | 0.110 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 564 | 0.110 |
Why?
|
| Stress, Physiological | 2 | 2013 | 1398 | 0.110 |
Why?
|
| Herpesvirus 4, Human | 2 | 2014 | 1075 | 0.110 |
Why?
|
| Trypsin Inhibitors | 1 | 2012 | 36 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2024 | 1279 | 0.110 |
Why?
|
| Repressor Proteins | 3 | 2000 | 2980 | 0.110 |
Why?
|
| Nucleoproteins | 1 | 2013 | 113 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 2 | 2000 | 2528 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2018 | 1047 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 3 | 2012 | 896 | 0.110 |
Why?
|
| Prognosis | 11 | 2021 | 29557 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 408 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2011 | 11709 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4455 | 0.100 |
Why?
|
| Triticum | 1 | 2012 | 89 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 1264 | 0.100 |
Why?
|
| Dysmenorrhea | 2 | 2024 | 98 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 1452 | 0.100 |
Why?
|
| Neoplasm Metastasis | 5 | 2020 | 4901 | 0.100 |
Why?
|
| Bone Marrow | 3 | 2019 | 2909 | 0.100 |
Why?
|
| Antigens, CD | 3 | 2008 | 3997 | 0.100 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2012 | 105 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2010 | 772 | 0.100 |
Why?
|
| Cardioplegic Solutions | 1 | 2012 | 122 | 0.100 |
Why?
|
| Plasmids | 4 | 2005 | 2275 | 0.100 |
Why?
|
| Transduction, Genetic | 5 | 2010 | 896 | 0.100 |
Why?
|
| Logistic Models | 3 | 2024 | 13276 | 0.100 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8544 | 0.100 |
Why?
|
| Mind-Body Therapies | 1 | 2015 | 266 | 0.100 |
Why?
|
| Mice, Inbred DBA | 4 | 2006 | 622 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 1309 | 0.100 |
Why?
|
| Parathyroid Hormone | 2 | 2011 | 1797 | 0.100 |
Why?
|
| Neoplasms | 7 | 2012 | 22032 | 0.100 |
Why?
|
| Disease Progression | 6 | 2021 | 13468 | 0.100 |
Why?
|
| Sequence Alignment | 4 | 2001 | 2176 | 0.100 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2010 | 102 | 0.100 |
Why?
|
| Prostate | 1 | 2000 | 1791 | 0.100 |
Why?
|
| Diclofenac | 1 | 2011 | 67 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 685 | 0.090 |
Why?
|
| Glioma | 4 | 1994 | 3418 | 0.090 |
Why?
|
| Drug Synergism | 3 | 2011 | 1745 | 0.090 |
Why?
|
| Mucin-6 | 1 | 2010 | 15 | 0.090 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2010 | 16 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 2 | 2010 | 1031 | 0.090 |
Why?
|
| Prostatic Hyperplasia | 1 | 2015 | 530 | 0.090 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2013 | 149 | 0.090 |
Why?
|
| Cell Proliferation | 9 | 2023 | 10416 | 0.090 |
Why?
|
| Synaptosomes | 2 | 2008 | 115 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2024 | 39059 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2007 | 1093 | 0.090 |
Why?
|
| Pregnancy | 8 | 2023 | 29742 | 0.090 |
Why?
|
| Immune System | 2 | 2013 | 796 | 0.090 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2010 | 54 | 0.090 |
Why?
|
| Cell Adhesion | 5 | 2014 | 3090 | 0.090 |
Why?
|
| Sesquiterpenes | 1 | 2011 | 176 | 0.090 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1990 | 62 | 0.090 |
Why?
|
| Boronic Acids | 3 | 2005 | 914 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 165 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 21017 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 3603 | 0.090 |
Why?
|
| Plant Proteins | 1 | 2012 | 369 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2010 | 3602 | 0.090 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 796 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2144 | 0.090 |
Why?
|
| Collagen Type X | 1 | 2010 | 16 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 1994 | 1455 | 0.090 |
Why?
|
| Epithelial Cells | 4 | 2007 | 3664 | 0.090 |
Why?
|
| Cell Death | 1 | 2015 | 1668 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 1994 | 719 | 0.090 |
Why?
|
| HeLa Cells | 6 | 2004 | 3096 | 0.090 |
Why?
|
| Epithelium | 3 | 2000 | 1605 | 0.090 |
Why?
|
| Rabbits | 3 | 2012 | 4772 | 0.090 |
Why?
|
| Young Adult | 13 | 2024 | 58808 | 0.090 |
Why?
|
| Alpha-Amanitin | 1 | 2009 | 7 | 0.090 |
Why?
|
| DNA Damage | 5 | 2006 | 2439 | 0.080 |
Why?
|
| Length of Stay | 2 | 2021 | 6439 | 0.080 |
Why?
|
| Hepatic Stellate Cells | 1 | 2010 | 119 | 0.080 |
Why?
|
| Adenoviruses, Human | 2 | 2002 | 255 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2004 | 350 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 481 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 453 | 0.080 |
Why?
|
| Blotting, Northern | 4 | 2004 | 1543 | 0.080 |
Why?
|
| Genes, Immunoglobulin | 1 | 1990 | 285 | 0.080 |
Why?
|
| Rats, Wistar | 5 | 2008 | 1844 | 0.080 |
Why?
|
| Proteins | 2 | 2020 | 6026 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 577 | 0.080 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 2 | 1999 | 15 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 2800 | 0.080 |
Why?
|
| Brain Neoplasms | 5 | 2006 | 8981 | 0.080 |
Why?
|
| Cycloheximide | 1 | 2009 | 343 | 0.080 |
Why?
|
| Fibroblasts | 9 | 2014 | 4087 | 0.080 |
Why?
|
| I-kappa B Proteins | 3 | 2005 | 211 | 0.080 |
Why?
|
| Cell-Derived Microparticles | 1 | 2010 | 161 | 0.080 |
Why?
|
| Luciferases | 5 | 2005 | 714 | 0.080 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2189 | 0.080 |
Why?
|
| Purkinje Cells | 1 | 2010 | 226 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1999 | 2895 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 2457 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 2942 | 0.080 |
Why?
|
| Cell Transformation, Viral | 2 | 2007 | 526 | 0.080 |
Why?
|
| Pyrazines | 3 | 2005 | 1198 | 0.080 |
Why?
|
| Predictive Value of Tests | 7 | 2024 | 15225 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2131 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2018 | 3047 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2004 | 3755 | 0.080 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 364 | 0.080 |
Why?
|
| Homeostasis | 2 | 2010 | 3301 | 0.080 |
Why?
|
| Cell Movement | 3 | 2016 | 5201 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 4 | 2015 | 4406 | 0.080 |
Why?
|
| Nerve Endings | 1 | 2008 | 105 | 0.080 |
Why?
|
| Osteoarthritis | 2 | 2008 | 1055 | 0.080 |
Why?
|
| Fetal Blood | 2 | 2012 | 1343 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 5759 | 0.070 |
Why?
|
| Transcription Factor RelA | 3 | 2005 | 250 | 0.070 |
Why?
|
| Metabolism | 1 | 2009 | 193 | 0.070 |
Why?
|
| Dendrites | 1 | 2010 | 474 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 2244 | 0.070 |
Why?
|
| Collagen Type II | 1 | 2008 | 148 | 0.070 |
Why?
|
| Carcinoma 256, Walker | 1 | 2007 | 38 | 0.070 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11070 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 5 | 2007 | 6068 | 0.070 |
Why?
|
| Incidence | 3 | 2021 | 21272 | 0.070 |
Why?
|
| Culture Media | 2 | 2006 | 899 | 0.070 |
Why?
|
| Microdissection | 1 | 2007 | 151 | 0.070 |
Why?
|
| Mice, Knockout | 6 | 2018 | 14354 | 0.070 |
Why?
|
| Shock, Hemorrhagic | 1 | 2009 | 223 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2012 | 849 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 14490 | 0.070 |
Why?
|
| Keratins | 2 | 2000 | 497 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2010 | 1154 | 0.070 |
Why?
|
| Mucins | 1 | 2010 | 568 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2009 | 1312 | 0.070 |
Why?
|
| Ketosis | 1 | 2007 | 46 | 0.070 |
Why?
|
| Somatomedins | 1 | 2007 | 178 | 0.070 |
Why?
|
| Umbilical Veins | 2 | 2005 | 426 | 0.070 |
Why?
|
| Ketone Bodies | 1 | 2007 | 76 | 0.070 |
Why?
|
| Pyrophosphatases | 1 | 2007 | 139 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2013 | 695 | 0.070 |
Why?
|
| Aging | 5 | 2023 | 8650 | 0.070 |
Why?
|
| Adenosine Triphosphate | 4 | 2008 | 1986 | 0.070 |
Why?
|
| Rats | 13 | 2009 | 23679 | 0.070 |
Why?
|
| Genes, Reporter | 5 | 2005 | 1527 | 0.070 |
Why?
|
| Mice, Inbred NOD | 4 | 2015 | 1825 | 0.070 |
Why?
|
| Restriction Mapping | 3 | 1993 | 852 | 0.070 |
Why?
|
| Epigenomics | 1 | 2012 | 936 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2007 | 198 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 192 | 0.070 |
Why?
|
| Metalloendopeptidases | 2 | 2005 | 393 | 0.070 |
Why?
|
| DNA | 11 | 2005 | 7199 | 0.070 |
Why?
|
| Risk Factors | 7 | 2024 | 73809 | 0.070 |
Why?
|
| Time Factors | 11 | 2024 | 39872 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 4 | 2014 | 3796 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1547 | 0.070 |
Why?
|
| Multiple Myeloma | 6 | 2005 | 5129 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 814 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 950 | 0.070 |
Why?
|
| Islets of Langerhans | 1 | 2012 | 1345 | 0.070 |
Why?
|
| Interferon-alpha | 1 | 2010 | 918 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2020 | 1927 | 0.070 |
Why?
|
| Gene Amplification | 3 | 1985 | 1085 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2012 | 761 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 124 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2020 | 3783 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2024 | 41256 | 0.060 |
Why?
|
| Anthracenes | 1 | 2005 | 83 | 0.060 |
Why?
|
| Esophageal Neoplasms | 2 | 2015 | 1648 | 0.060 |
Why?
|
| Adolescent | 13 | 2024 | 87892 | 0.060 |
Why?
|
| Rifabutin | 1 | 2005 | 58 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2003 | 103 | 0.060 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2007 | 341 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1999 | 1055 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 11 | 2012 | 22003 | 0.060 |
Why?
|
| Disintegrins | 1 | 2005 | 27 | 0.060 |
Why?
|
| Endothelium | 2 | 2004 | 764 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2010 | 1150 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2011 | 1893 | 0.060 |
Why?
|
| Epidermal Growth Factor | 8 | 1998 | 695 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2007 | 265 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1444 | 0.060 |
Why?
|
| Nucleotides | 1 | 2008 | 450 | 0.060 |
Why?
|
| 3T3 Cells | 3 | 2002 | 1084 | 0.060 |
Why?
|
| Adult Stem Cells | 1 | 2007 | 221 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2005 | 380 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 986 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2006 | 169 | 0.060 |
Why?
|
| Quinazolinones | 1 | 2006 | 221 | 0.060 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2008 | 373 | 0.060 |
Why?
|
| Collagenases | 1 | 2005 | 221 | 0.060 |
Why?
|
| Growth Substances | 1 | 1987 | 768 | 0.060 |
Why?
|
| Integrins | 2 | 2007 | 836 | 0.060 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2008 | 412 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2013 | 2433 | 0.060 |
Why?
|
| DNA Modification Methylases | 1 | 2005 | 209 | 0.060 |
Why?
|
| Celiac Disease | 1 | 2012 | 822 | 0.060 |
Why?
|
| Apyrase | 1 | 2007 | 373 | 0.060 |
Why?
|
| Urine | 1 | 2006 | 363 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 4 | 2010 | 1332 | 0.060 |
Why?
|
| Lasers | 2 | 2007 | 952 | 0.060 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 189 | 0.060 |
Why?
|
| Protein Precursors | 2 | 1999 | 1133 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2009 | 1197 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 12075 | 0.060 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2007 | 261 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2011 | 5249 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2015 | 4023 | 0.060 |
Why?
|
| Mesoderm | 1 | 2007 | 672 | 0.060 |
Why?
|
| Jurkat Cells | 3 | 2015 | 735 | 0.060 |
Why?
|
| Thrombosis | 1 | 2018 | 2929 | 0.060 |
Why?
|
| Sepsis | 1 | 2018 | 2587 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 17768 | 0.060 |
Why?
|
| Azacitidine | 1 | 2005 | 334 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 4809 | 0.060 |
Why?
|
| Leukemia, B-Cell | 1 | 2004 | 84 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 1705 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2012 | 1111 | 0.060 |
Why?
|
| Catenins | 1 | 2023 | 41 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 670 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 898 | 0.060 |
Why?
|
| Angiopoietin-1 | 1 | 2004 | 122 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 4711 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 695 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1136 | 0.050 |
Why?
|
| Alternative Splicing | 2 | 1999 | 1090 | 0.050 |
Why?
|
| Albumins | 1 | 2006 | 575 | 0.050 |
Why?
|
| High Mobility Group Proteins | 2 | 2008 | 177 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2016 | 2275 | 0.050 |
Why?
|
| Glioblastoma | 3 | 2006 | 3480 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 6520 | 0.050 |
Why?
|
| United States | 6 | 2024 | 72136 | 0.050 |
Why?
|
| Research Design | 2 | 2017 | 6157 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1335 | 0.050 |
Why?
|
| Cricetinae | 2 | 1999 | 2426 | 0.050 |
Why?
|
| NFATC Transcription Factors | 1 | 2005 | 381 | 0.050 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2002 | 31 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2009 | 2907 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 121 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2012 | 3432 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2005 | 423 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 1477 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 1186 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 597 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2007 | 1245 | 0.050 |
Why?
|
| Genetic Markers | 3 | 2018 | 2608 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2022 | 8553 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1895 | 0.050 |
Why?
|
| Herpesvirus 8, Human | 1 | 2004 | 255 | 0.050 |
Why?
|
| Granulocytes | 2 | 2019 | 550 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 189 | 0.050 |
Why?
|
| Heart Ventricles | 3 | 2012 | 3806 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 5 | 1987 | 1304 | 0.050 |
Why?
|
| Cognition | 2 | 2020 | 6953 | 0.050 |
Why?
|
| COS Cells | 1 | 2004 | 1128 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 906 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2413 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2010 | 2322 | 0.050 |
Why?
|
| Models, Biological | 8 | 2008 | 9460 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 25956 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2007 | 3617 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 638 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2002 | 283 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 828 | 0.050 |
Why?
|
| Protein Transport | 2 | 2005 | 1963 | 0.050 |
Why?
|
| Peptides | 3 | 2010 | 4341 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3211 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 3 | 2010 | 321 | 0.050 |
Why?
|
| Chromosome Mapping | 4 | 1997 | 4624 | 0.050 |
Why?
|
| Exons | 3 | 2010 | 2387 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 1999 | 818 | 0.050 |
Why?
|
| Kidney | 6 | 2021 | 7016 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2024 | 64378 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 1987 | 867 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2003 | 254 | 0.050 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 215 | 0.050 |
Why?
|
| Cartilage, Articular | 1 | 2008 | 1091 | 0.050 |
Why?
|
| CpG Islands | 1 | 2005 | 1221 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1262 | 0.050 |
Why?
|
| Swine Diseases | 1 | 2020 | 62 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2018 | 506 | 0.050 |
Why?
|
| Bone Resorption | 1 | 2004 | 720 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1997 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2013 | 3530 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2000 | 58 | 0.040 |
Why?
|
| Membrane Glycoproteins | 3 | 2001 | 3705 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2420 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2020 | 72 | 0.040 |
Why?
|
| Androgens | 2 | 2005 | 1291 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 900 | 0.040 |
Why?
|
| Selection Bias | 1 | 2022 | 357 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2020 | 24 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2020 | 28 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2006 | 3599 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 224 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2004 | 358 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3584 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 869 | 0.040 |
Why?
|
| Salivary Proteins and Peptides | 1 | 1999 | 48 | 0.040 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 60 | 0.040 |
Why?
|
| Gene Products, gag | 1 | 2000 | 312 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 2013 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 655 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 36284 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 2105 | 0.040 |
Why?
|
| Bradykinin | 1 | 1999 | 208 | 0.040 |
Why?
|
| Endocrine System | 1 | 2020 | 112 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2002 | 441 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2009 | 1881 | 0.040 |
Why?
|
| Oncogenes | 4 | 2003 | 1220 | 0.040 |
Why?
|
| In Situ Hybridization | 4 | 2005 | 1900 | 0.040 |
Why?
|
| Lipomatosis | 1 | 2020 | 112 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2859 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 665 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1694 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 2012 | 2672 | 0.040 |
Why?
|
| Kinetics | 6 | 2008 | 6371 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2007 | 1991 | 0.040 |
Why?
|
| Goldfish | 1 | 1998 | 65 | 0.040 |
Why?
|
| HEK293 Cells | 3 | 2013 | 4257 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2002 | 754 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2010 | 1125 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2003 | 868 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1785 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 522 | 0.040 |
Why?
|
| Temperature | 1 | 2005 | 2219 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2022 | 670 | 0.040 |
Why?
|
| Plasma | 1 | 2022 | 584 | 0.040 |
Why?
|
| Mice, Inbred C3H | 2 | 2012 | 915 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 550 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1999 | 175 | 0.040 |
Why?
|
| Genome | 1 | 2007 | 1739 | 0.040 |
Why?
|
| Consensus Sequence | 2 | 1996 | 365 | 0.040 |
Why?
|
| Child | 8 | 2022 | 79818 | 0.040 |
Why?
|
| Sodium Azide | 2 | 2008 | 24 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 1693 | 0.040 |
Why?
|
| Piperidines | 1 | 2006 | 1639 | 0.040 |
Why?
|
| Bone Marrow Diseases | 1 | 2020 | 232 | 0.040 |
Why?
|
| Suramin | 2 | 2008 | 34 | 0.040 |
Why?
|
| beta Catenin | 1 | 2023 | 1043 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1878 | 0.040 |
Why?
|
| Cell Communication | 1 | 2005 | 1651 | 0.040 |
Why?
|
| Child, Preschool | 6 | 2021 | 42062 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2005 | 617 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2010 | 102 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 374 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1674 | 0.040 |
Why?
|
| Adenoviridae Infections | 1 | 1998 | 93 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1317 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 582 | 0.040 |
Why?
|
| Estradiol | 1 | 2004 | 1933 | 0.040 |
Why?
|
| Bone and Bones | 2 | 2005 | 2560 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 1997 | 248 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 1999 | 602 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 1998 | 402 | 0.040 |
Why?
|
| Angiopoietin-2 | 1 | 2018 | 172 | 0.040 |
Why?
|
| Phenotype | 5 | 2020 | 16534 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20500 | 0.030 |
Why?
|
| Endocytosis | 2 | 2020 | 958 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1063 | 0.030 |
Why?
|
| Hydrolysis | 2 | 2008 | 664 | 0.030 |
Why?
|
| Poly A | 2 | 1994 | 181 | 0.030 |
Why?
|
| Fetal Proteins | 1 | 1996 | 97 | 0.030 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 12096 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2004 | 2666 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2003 | 4902 | 0.030 |
Why?
|
| CHO Cells | 1 | 1999 | 1389 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 2018 | 1484 | 0.030 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 9518 | 0.030 |
Why?
|
| Introns | 1 | 1999 | 978 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2020 | 656 | 0.030 |
Why?
|
| Adenosine Diphosphate | 2 | 2008 | 422 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 1997 | 553 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1066 | 0.030 |
Why?
|
| Fibronectins | 2 | 2018 | 722 | 0.030 |
Why?
|
| Leukemia | 1 | 2004 | 1519 | 0.030 |
Why?
|
| Teriparatide | 1 | 1997 | 227 | 0.030 |
Why?
|
| Dinoprostone | 2 | 1997 | 598 | 0.030 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2047 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 706 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 2189 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2018 | 562 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 778 | 0.030 |
Why?
|
| Prednisone | 1 | 2020 | 1565 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2018 | 883 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 2912 | 0.030 |
Why?
|
| Retina | 2 | 2003 | 2635 | 0.030 |
Why?
|
| Bucladesine | 1 | 1994 | 118 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2021 | 785 | 0.030 |
Why?
|
| Alprostadil | 1 | 1994 | 86 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1997 | 1759 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 672 | 0.030 |
Why?
|
| Stem Cells | 2 | 2006 | 3521 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2019 | 2533 | 0.030 |
Why?
|
| Theophylline | 1 | 1994 | 131 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1994 | 422 | 0.030 |
Why?
|
| Cell Count | 1 | 2018 | 1835 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 566 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 621 | 0.030 |
Why?
|
| RNA, Neoplasm | 2 | 2008 | 749 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1993 | 74 | 0.030 |
Why?
|
| Connective Tissue | 1 | 1996 | 416 | 0.030 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2013 | 40 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2009 | 4641 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 1721 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2005 | 11152 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1177 | 0.030 |
Why?
|
| Viral Structural Proteins | 1 | 2013 | 95 | 0.030 |
Why?
|
| Misoprostol | 1 | 1994 | 93 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3975 | 0.030 |
Why?
|
| Extracellular Space | 2 | 2008 | 564 | 0.030 |
Why?
|
| DNA Repair | 1 | 2002 | 2038 | 0.030 |
Why?
|
| Hordeum | 1 | 2012 | 18 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2005 | 2523 | 0.030 |
Why?
|
| DNA Probes | 1 | 1994 | 543 | 0.030 |
Why?
|
| Cartilage | 2 | 2008 | 806 | 0.030 |
Why?
|
| Acute Disease | 2 | 2018 | 7225 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 419 | 0.030 |
Why?
|
| Gliadin | 1 | 2012 | 80 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 2154 | 0.030 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 672 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1203 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1141 | 0.030 |
Why?
|
| Enzyme Inhibitors | 4 | 2007 | 3709 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2008 | 1686 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2022 | 1469 | 0.030 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2013 | 131 | 0.030 |
Why?
|
| U937 Cells | 1 | 2012 | 262 | 0.030 |
Why?
|
| Bone Marrow Cells | 3 | 2009 | 2414 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1723 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 61 | 0.030 |
Why?
|
| Phylogeny | 1 | 2000 | 2774 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2018 | 1149 | 0.030 |
Why?
|
| Ovariectomy | 2 | 2004 | 610 | 0.030 |
Why?
|
| Receptors, TIE | 2 | 2002 | 10 | 0.030 |
Why?
|
| Receptor, TIE-1 | 2 | 2002 | 13 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2006 | 1792 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2012 | 126 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 1994 | 442 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2014 | 491 | 0.020 |
Why?
|
| Intestines | 1 | 2021 | 1906 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 783 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 204 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2004 | 1890 | 0.020 |
Why?
|
| Hepatocytes | 2 | 2011 | 1230 | 0.020 |
Why?
|
| Ligation | 1 | 2012 | 448 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 18119 | 0.020 |
Why?
|
| Fasting | 1 | 2018 | 1599 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2024 | 2147 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1992 | 1801 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5816 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1996 | 913 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 372 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 2012 | 10171 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10748 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2000 | 3156 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 420 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2504 | 0.020 |
Why?
|
| Bone Density | 1 | 2004 | 3533 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 1486 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2714 | 0.020 |
Why?
|
| Immune Tolerance | 2 | 2012 | 2297 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 7 | 2012 | 9160 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2001 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2005 | 4373 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 229 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1165 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5892 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1990 | 221 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 13961 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 127 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2002 | 3733 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2010 | 3 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5199 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2010 | 20 | 0.020 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Teratocarcinoma | 1 | 2010 | 16 | 0.020 |
Why?
|
| Tubulin | 1 | 1994 | 692 | 0.020 |
Why?
|
| Epitopes | 4 | 2002 | 2502 | 0.020 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2010 | 26 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2012 | 495 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1793 | 0.020 |
Why?
|
| Expert Systems | 1 | 2010 | 79 | 0.020 |
Why?
|
| Ubiquitin | 2 | 2007 | 837 | 0.020 |
Why?
|
| DNA, Viral | 2 | 1998 | 2194 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2010 | 56 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1992 | 438 | 0.020 |
Why?
|
| Lung | 2 | 2022 | 9985 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2004 | 5917 | 0.020 |
Why?
|
| tau Proteins | 1 | 2020 | 2085 | 0.020 |
Why?
|
| RNA | 3 | 2008 | 2716 | 0.020 |
Why?
|
| Chick Embryo | 2 | 2002 | 981 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 1060 | 0.020 |
Why?
|
| Boston | 1 | 2022 | 9304 | 0.020 |
Why?
|
| Chickens | 2 | 2002 | 860 | 0.020 |
Why?
|
| Astrocytoma | 1 | 1994 | 775 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 2009 | 151 | 0.020 |
Why?
|
| Feces | 1 | 2016 | 1456 | 0.020 |
Why?
|
| Virus Replication | 1 | 1997 | 2430 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 204 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2011 | 2047 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2012 | 478 | 0.020 |
Why?
|
| Genotype | 2 | 2020 | 12945 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 414 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1507 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2012 | 3485 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2004 | 4106 | 0.020 |
Why?
|
| SOXC Transcription Factors | 1 | 2008 | 41 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1999 | 3441 | 0.020 |
Why?
|
| Simplexvirus | 1 | 1992 | 803 | 0.020 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 51 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6895 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 1342 | 0.020 |
Why?
|
| Premature Birth | 1 | 2020 | 1771 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 581 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 482 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 826 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 795 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 63 | 0.020 |
Why?
|
| Macrophages | 1 | 2003 | 5737 | 0.020 |
Why?
|
| Cystatins | 1 | 2008 | 55 | 0.020 |
Why?
|
| Thymidine Monophosphate | 1 | 2007 | 2 | 0.020 |
Why?
|
| Growth Plate | 1 | 2010 | 274 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 258 | 0.020 |
Why?
|
| Receptors, Virus | 2 | 2002 | 639 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2007 | 46 | 0.020 |
Why?
|
| Anxiety | 1 | 2023 | 4539 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2012 | 732 | 0.020 |
Why?
|
| Ouabain | 1 | 2008 | 247 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 294 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 489 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1993 | 1074 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2129 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3071 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 7021 | 0.020 |
Why?
|
| Tissue Banks | 1 | 2008 | 184 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 490 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2007 | 111 | 0.020 |
Why?
|
| Thioacetamide | 1 | 2006 | 22 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2008 | 222 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2002 | 6548 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3563 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2008 | 302 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2007 | 169 | 0.020 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2007 | 72 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2022 | 6187 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2006 | 139 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 238 | 0.020 |
Why?
|
| Placenta | 2 | 2006 | 1702 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36055 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 2007 | 102 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2006 | 145 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6768 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2006 | 166 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1651 | 0.020 |
Why?
|
| Cystatin C | 1 | 2008 | 270 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8823 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2008 | 228 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 1094 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 146 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2221 | 0.020 |
Why?
|
| Oncogenic Viruses | 1 | 1986 | 37 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1987 | 534 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 748 | 0.020 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2005 | 14 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 14641 | 0.020 |
Why?
|
| Globins | 1 | 2006 | 403 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2004 | 2378 | 0.020 |
Why?
|
| Integrin alpha2beta1 | 1 | 2005 | 17 | 0.020 |
Why?
|
| Integrin alpha6beta4 | 1 | 2005 | 30 | 0.020 |
Why?
|
| Protein Kinase C | 2 | 2001 | 1199 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 825 | 0.020 |
Why?
|
| Smad1 Protein | 1 | 2005 | 81 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2005 | 2443 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15785 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 544 | 0.020 |
Why?
|
| raf Kinases | 1 | 2005 | 118 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2004 | 11 | 0.020 |
Why?
|
| Meningioma | 1 | 1994 | 1217 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2005 | 198 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2005 | 351 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2004 | 42 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 158 | 0.020 |
Why?
|
| Osteopontin | 1 | 2006 | 301 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2005 | 276 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2004 | 65 | 0.020 |
Why?
|
| Diet | 1 | 2023 | 8005 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 1994 | 1247 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 1743 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10495 | 0.020 |
Why?
|
| Disease | 1 | 2010 | 671 | 0.010 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2004 | 44 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1984 | 2185 | 0.010 |
Why?
|
| Caloric Restriction | 1 | 2007 | 296 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2004 | 115 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2239 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 1972 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2005 | 250 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 9416 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2005 | 226 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2004 | 134 | 0.010 |
Why?
|
| Genes, jun | 1 | 2003 | 68 | 0.010 |
Why?
|
| Integrin alpha6 | 1 | 2003 | 30 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2008 | 2262 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 435 | 0.010 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2005 | 217 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6457 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 148 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 2005 | 315 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 1172 | 0.010 |
Why?
|
| Laminin | 1 | 2005 | 405 | 0.010 |
Why?
|
| ADAM Proteins | 1 | 2005 | 238 | 0.010 |
Why?
|
| Cathepsins | 1 | 2004 | 241 | 0.010 |
Why?
|
| Asthma | 1 | 2002 | 6172 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 342 | 0.010 |
Why?
|
| Genes, fos | 1 | 2003 | 173 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 1539 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2005 | 431 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8611 | 0.010 |
Why?
|
| Ligands | 2 | 2002 | 3258 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2007 | 10112 | 0.010 |
Why?
|
| E-Selectin | 1 | 2005 | 576 | 0.010 |
Why?
|
| Sp3 Transcription Factor | 1 | 2002 | 28 | 0.010 |
Why?
|
| Cerebellum | 1 | 2010 | 1497 | 0.010 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2002 | 13 | 0.010 |
Why?
|
| Risk | 1 | 2015 | 9599 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 703 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2003 | 530 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 2497 | 0.010 |
Why?
|
| Depression | 1 | 2023 | 8057 | 0.010 |
Why?
|
| Survival Rate | 2 | 2009 | 12721 | 0.010 |
Why?
|
| Thrombin | 1 | 2005 | 590 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 2003 | 79 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 691 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 2003 | 320 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 330 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1985 | 388 | 0.010 |
Why?
|
| Chemokine CCL20 | 1 | 2002 | 63 | 0.010 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2005 | 276 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2002 | 142 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2010 | 1866 | 0.010 |
Why?
|
| Glycoproteins | 3 | 2004 | 2205 | 0.010 |
Why?
|
| Receptors, CCR6 | 1 | 2002 | 73 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2850 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 459 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15651 | 0.010 |
Why?
|
| Protein Kinases | 3 | 1984 | 1610 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 996 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 614 | 0.010 |
Why?
|
| Bone Development | 1 | 2005 | 472 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2002 | 140 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 670 | 0.010 |
Why?
|
| Mouth Neoplasms | 1 | 2007 | 593 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2005 | 801 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2007 | 2381 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2003 | 326 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2002 | 364 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 2003 | 222 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6821 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 2108 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 555 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 611 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6493 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1982 | 201 | 0.010 |
Why?
|
| Mitogens | 1 | 1982 | 230 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 449 | 0.010 |
Why?
|
| Prolactin | 1 | 1983 | 621 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 8143 | 0.010 |
Why?
|
| Age of Onset | 1 | 2008 | 3298 | 0.010 |
Why?
|
| Allantois | 1 | 2001 | 33 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 1133 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 286 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1983 | 367 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 1892 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 3425 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 1152 | 0.010 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2005 | 479 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1585 | 0.010 |
Why?
|
| Melphalan | 1 | 2002 | 420 | 0.010 |
Why?
|
| Chorion | 1 | 2001 | 114 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1705 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1983 | 637 | 0.010 |
Why?
|
| Cryopreservation | 1 | 2006 | 717 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2004 | 598 | 0.010 |
Why?
|
| Synaptotagmin I | 1 | 2000 | 33 | 0.010 |
Why?
|
| Synaptotagmins | 1 | 2000 | 53 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2017 | 23884 | 0.010 |
Why?
|
| Motor Activity | 1 | 2010 | 2685 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2796 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 12876 | 0.010 |
Why?
|
| Ultraviolet Rays | 2 | 2002 | 1076 | 0.010 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 1008 | 0.010 |
Why?
|
| India | 1 | 2007 | 2329 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2012 | 3299 | 0.010 |
Why?
|
| Half-Life | 1 | 2001 | 652 | 0.010 |
Why?
|
| Body Fluids | 1 | 1982 | 319 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 548 | 0.010 |
Why?
|
| Spectrin | 1 | 1980 | 170 | 0.010 |
Why?
|
| Lymphokines | 1 | 2003 | 926 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1999 | 102 | 0.010 |
Why?
|
| Response Elements | 1 | 2001 | 308 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12951 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 4919 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2005 | 1326 | 0.010 |
Why?
|
| Tibia | 1 | 2005 | 1065 | 0.010 |
Why?
|
| Actins | 2 | 2004 | 2049 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1630 | 0.010 |
Why?
|
| Maleimides | 1 | 1999 | 113 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1985 | 1745 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 1055 | 0.010 |
Why?
|
| ets-Domain Protein Elk-4 | 1 | 1998 | 5 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2005 | 2020 | 0.010 |
Why?
|
| Postmenopause | 1 | 2008 | 2509 | 0.010 |
Why?
|
| Femur | 1 | 2005 | 1302 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 989 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1998 | 97 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 331 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2000 | 316 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 1980 | 439 | 0.010 |
Why?
|
| Estrogens | 1 | 2005 | 1520 | 0.010 |
Why?
|
| Cell Membrane | 3 | 1984 | 3680 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2002 | 658 | 0.010 |
Why?
|
| Immunoconjugates | 1 | 2006 | 949 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 924 | 0.010 |
Why?
|
| Bronchi | 1 | 2002 | 848 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 795 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 1812 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 829 | 0.010 |
Why?
|
| Benzylamines | 1 | 1999 | 247 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 1007 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 1735 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 3020 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2002 | 914 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 213 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 4353 | 0.010 |
Why?
|
| Fever | 1 | 2005 | 1617 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 1526 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5490 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 237 | 0.010 |
Why?
|
| Pyrroles | 1 | 2004 | 1130 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2002 | 1996 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2002 | 1806 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1998 | 215 | 0.010 |
Why?
|
| Gestational Age | 1 | 2006 | 3565 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1998 | 473 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 4549 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 2635 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1600 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1997 | 255 | 0.010 |
Why?
|
| Brain | 3 | 2006 | 26947 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3099 | 0.010 |
Why?
|
| Chromatin | 1 | 2008 | 2938 | 0.010 |
Why?
|
| Connective Tissue Cells | 1 | 1996 | 50 | 0.010 |
Why?
|
| Transforming Growth Factors | 2 | 1988 | 75 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 3527 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2002 | 2209 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 3612 | 0.010 |
Why?
|
| Weight Loss | 1 | 2007 | 2671 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1998 | 494 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 1233 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2001 | 1112 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2553 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 2016 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2007 | 26183 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2004 | 1598 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2008 | 3941 | 0.010 |
Why?
|
| Branchioma | 1 | 1953 | 17 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 588 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 1593 | 0.010 |
Why?
|
| Zygoma | 1 | 1953 | 52 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5864 | 0.010 |
Why?
|
| ras Proteins | 1 | 1998 | 1049 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1997 | 1414 | 0.010 |
Why?
|
| Cyanogen Bromide | 2 | 1983 | 73 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12604 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8530 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1160 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1996 | 1339 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1997 | 897 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2004 | 3006 | 0.010 |
Why?
|
| Indoles | 1 | 1999 | 1828 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1980 | 2413 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2001 | 2690 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80168 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18358 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 8426 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 12870 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1999 | 1973 | 0.010 |
Why?
|
| Internet | 1 | 2002 | 3082 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2006 | 5649 | 0.000 |
Why?
|
| Cysts | 1 | 1953 | 681 | 0.000 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1988 | 178 | 0.000 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1985 | 32 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1985 | 77 | 0.000 |
Why?
|
| DNA Replication | 2 | 1983 | 1410 | 0.000 |
Why?
|
| Antibodies | 2 | 1984 | 2420 | 0.000 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1984 | 75 | 0.000 |
Why?
|
| Rodentia | 1 | 1986 | 260 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1983 | 76 | 0.000 |
Why?
|
| Blood Group Antigens | 1 | 1985 | 187 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2002 | 15773 | 0.000 |
Why?
|
| Phosphotyrosine | 1 | 1983 | 455 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 513 | 0.000 |
Why?
|
| Hybridomas | 1 | 1983 | 442 | 0.000 |
Why?
|
| Vinculin | 1 | 1982 | 59 | 0.000 |
Why?
|
| Biophysical Phenomena | 1 | 1983 | 320 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1983 | 1060 | 0.000 |
Why?
|
| Biophysics | 1 | 1983 | 380 | 0.000 |
Why?
|
| Oligosaccharides | 1 | 1983 | 403 | 0.000 |
Why?
|
| Allosteric Regulation | 1 | 1983 | 426 | 0.000 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1983 | 444 | 0.000 |
Why?
|
| Microinjections | 1 | 1982 | 321 | 0.000 |
Why?
|
| Skin Physiological Phenomena | 1 | 1982 | 188 | 0.000 |
Why?
|
| Affinity Labels | 1 | 1980 | 107 | 0.000 |
Why?
|
| Peptide Fragments | 2 | 1984 | 5098 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 1433 | 0.000 |
Why?
|
| Caseins | 1 | 1980 | 103 | 0.000 |
Why?
|
| Tyrosine | 1 | 1983 | 1432 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 1953 | 2882 | 0.000 |
Why?
|
| Surface Properties | 1 | 1982 | 1159 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1983 | 1529 | 0.000 |
Why?
|
| Fetus | 1 | 1985 | 1859 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1983 | 3069 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1980 | 588 | 0.000 |
Why?
|
| Mitosis | 1 | 1983 | 1191 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1982 | 1607 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1983 | 1434 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1980 | 5629 | 0.000 |
Why?
|